Relationship between functional imaging and immunohistochemical markers and prediction of breast cancer subtype: a PET/MRI study-Reference-Cited by-同舟云学术

Relationship between functional imaging and immunohistochemical markers and prediction of breast cancer subtype: a PET/MRI study

Published:2018-04-25 Issue:10 Volume:45 Page:1680-1693
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Incoronato Mariarosaria,Grimaldi Anna Maria,Cavaliere Carlo,Inglese Marianna,Mirabelli Peppino,Monti Serena,Ferbo Umberto,Nicolai Emanuele,Soricelli Andrea,Catalano Onofrio Antonio,Aiello Marco,Salvatore Marco

Funder

This study was supported by “Ricerca Corrente” funding from the Italian Ministry of Health and partially by "5 per mille" IRCCS SDN grant.

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/article/10.1007/s00259-018-4010-7/fulltext.html

Reference53 articles.

1. Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Thurlimann B, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol. 2013;24:2206–23. https://doi.org/10.1093/annonc/mdt303 .

2. Ueda S, Tsuda H, Asakawa H, Shigekawa T, Fukatsu K, Kondo N, et al. Clinicopathological and prognostic relevance of uptake level using F-18-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (F-18-FDG PET/CT) in primary breast cancer. Jpn J Clin Oncol. 2008;38:250–8. https://doi.org/10.1093/jjco/hyn019 .

3. Osborne JR, Port E, Gonen M, Doane AS, Yeung H, Gerald W, et al. F-18-FDG PET of locally invasive breast cancer and association of estrogen receptor status with standardized uptake value: microarray and immunohistochemical analysis. J Nucl Med. 2010;51:543–50. https://doi.org/10.2967/jnumed.108.060459 .

4. Heudel P, Cimarelli S, Montella A, Bouteille C, Mognetti T. Value of PET-FDG in primary breast cancer based on histopathological and immunohistochemical prognostic factors. Int J Clin Oncol. 2010;15:588–93. https://doi.org/10.1007/s10147-010-0120-3 .

5. Groheux D, Giacchetti S, Moretti JL, Porcher R, Espie M, Lehmann-Che J, et al. Correlation of high F-18-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer. Eur J Nucl Med Mol Imaging. 2011;38:426–35. https://doi.org/10.1007/s00259-010-1640-9 .

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer;European Journal of Nuclear Medicine and Molecular Imaging;2024-05-14

2. Abdominal Positron Emission Tomography/Magnetic Resonance Imaging;Magnetic Resonance Imaging Clinics of North America;2023-11

3. The Clinical Added Value of Breast Cancer Imaging Using Hybrid PET/MR Imaging;Magnetic Resonance Imaging Clinics of North America;2023-11

4. The synergistic effect of PET/MRI in whole-body oncologic imaging: an Expert Review;Clinical and Translational Imaging;2023-07-13

5. Discordant and Converting Receptor Expressions in Brain Metastases from Breast Cancer: MRI-Based Non-Invasive Receptor Status Tracking;Cancers;2023-05-23